Immunogenicity 11934
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ILDR2
Transcript ID
uc001gdx.2
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (639 aa)
MDRVL
1
LRWIS
6
LFWLT
11
AMVEG
16
LQVTV
21
PDKKK
26
VAMLF
31
QPTVL
36
RCHFS
41
TSSHQ
46
PAVVQ
51
WKFKS
56
YCQDR
61
MGESL
66
GMSST
71
RAQSL
76
SKRNL
81
EWDPY
86
LDCLD
91
SRRTV
96
RVVAS
101
KQGST
106
VTLGD
111
FYRGR
116
EITIV
121
HDADL
126
QIGKL
131
MWGDS
136
GLYYC
141
IITTP
146
DDLEG
151
KNEDS
156
VELLV
161
LGRTG
166
LLADL
171
LPSFA
176
VEIMP
181
EWVFV
186
GLVLL
191
GVFLF
196
FVLVG
201
ICWCQ
206
CCPHS
211
CCCYV
216
RCPCC
221
PDSCC
226
CPQAL
231
YEAGK
236
AAKAG
241
YPPSV
246
SGVPG
251
PYSIP
256
SVPLG
261
GAPSS
266
GMLMD
271
KPHPP
276
PLAPS
281
DSTGG
286
SHSVR
291
KGYRI
296
QADKE
301
RDSMK
306
VLYYV
311
EKELA
316
QFDPA
321
RRMRG
326
RYNNT
331
ISELS
336
SLHEE
341
DSNFR
346
QSFHQ
351
MRSKQ
356
FPVSG
361
DLESN
366
PDYWS
371
GVMGG
376
SSGAS
381
RGPSA
386
MEYNK
391
EDRES
396
FRHSQ
401
PRSKS
406
EMLSR
411
KNFAT
416
GVPAV
421
SMDEL
426
AAFAD
431
SYGQR
436
PRRAD
441
GNSHE
446
ARGGS
451
RFERS
456
ESRAH
461
SGFYQ
466
DDSLE
471
EYYGQ
476
RSRSR
481
EPLTD
486
ADRGW
491
AFSPA
496
RRRPA
501
EDAHL
506
PRLVS
511
RTPGT
516
APKYD
521
HSYLG
526
SARER
531
QARPE
536
GASRG
541
GSLET
546
PSKRS
551
AQLGP
556
RSASY
561
YAWSP
566
PGTYK
571
AGSSQ
576
DDQED
581
ASDDA
586
LPPYS
591
ELELT
596
RGPSY
601
RGRDL
606
PYHSN
611
SEKKR
616
KKEPA
621
KKTND
626
FPTRM
631
SLVV
636
Mutation Information
DNA mutation:
None
Peptide Range:
227 ~ 251
Mut AA position:
239 (13 in Wild Type peptide)
Alignment
Wild Type:
"DSCCCPQALYEAGKAAKAGYPPSVS
||||||||||||.||||||||||||
Mutant:
DSCCCPQALYEAEKAAKAGYPPSVS"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ILDR2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay